Advance innovation with structured execution - from formulation risk checks to pilot readiness, built for compliant launch.
Innovation to Commercialisation Program supports brands in transforming scientific and technical concepts into compliant, market-ready products. From early-stage feasibility and regulatory risk analysis to development guidance and launch alignment, the program embeds execution foresight into every phase of innovation.
Structured Journey to
ComplianceBuilt to guide every step with clarity, speed, and regulatory precision - from planning to execution.
In-depth review of formulation, ingredient acceptability, and dossier availability to evaluate regulatory readiness.
Strategic analysis to identify accessible markets for the product based on category fit, regulatory pathways, and compliance barriers.
Identification of optimal submission pathways based on product type and target market.
Detailed checklist of regulatory documents, technical files, and data required and gap analysis per region and product classification.
Market-by-market estimation of approval timelines and milestone planning to align internal launch schedules and supply readiness.
For digitally regulated markets (e.g., US, EU, GCC)
For ASEAN markets following harmonized technical standards
For regions accepting non-eCTD digital structures
For markets with unique formats, administrative structures, or local language needs
Preparation and filing of product-specific regulatory applications
End-to-end management of Drug Master Files and Chemistry, Manufacturing & Controls sections
Handling of regulatory queries, clarification requests, and pre/post-submission communication
Acting as the local MAH in eligible markets to enable compliant registration
Leveraging trusted local partners to hold MAH with oversight from Regnova
Serving as the official local representative for regulatory interactions
Analyse target market trends, applicable regulatory classifications, and category-specific challenges.
Evaluate ingredient acceptability, restrictions, and pre-approval status based on regional regulations.
Assess chemical, functional, and regulatory compatibility between components in the intended formulation.
Conduct trials to determine stability, solubility, and potential interactions of selected ingredients.
Establish the complete technical formulation, listing all components with defined specifications.
Prepare small-scale batches to validate formulation performance and process parameters.
Assess key properties such as pH, viscosity, dispersion, and appearance for initial quality benchmarks.
Execute limited-scale production runs to simulate commercial manufacturing conditions and process scalability.
Conduct validated analytical testing and ICH-compliant stability studies to establish product shelf life.
Evaluate the safety and performance profile through clinical data review or documented claims substantiation.
Ensure formulation and process compatibility with identified CDMOs or manufacturing partners.
Assess packaging formats for compatibility, stability, regulatory compliance, and cost efficiency.
Establish automated or manual workflows for capturing and reporting adverse events as per global requirements.
Analyse cumulative safety data to identify new risks and assess evolving product benefit-risk profiles.
Process AE reports, evaluate causality, and submit cases to relevant health authorities using approved formats.
Create compliant, product-specific procedures for logging, reviewing, and closing complaints.
Deploy digital or manual systems to capture complaints and trigger structured investigations.
Apply structured problem-solving tools to uncover systemic or recurring product issues.
Monitor and report on complaint patterns to detect early warning signs and improve product performance.
Prepare summaries of safety data and regulatory actions for ongoing benefit-risk assessment.
Generate Post-Market Clinical Follow-up reports to demonstrate continued device safety and effectiveness.
Analyse adverse event or complaint trends to meet EU MDR surveillance requirements.
Compile jurisdiction-specific reports as required for ongoing local market approvals.
Services
Connect with vetted manufacturing partners to scale your formulation into compliant commercial batches
Navigate tech transfer and licensing with regulatory alignment across CDMOs, CMOs, and local partners
Access expert input on formulation, testing protocols, and technical documentation to support smooth scale-up
Assess and qualify manufacturing facilities to ensure regulatory, quality, and capacity readiness.
USP
Flexibility
Pilot-to-Scale Execution
Structured Execution Model
Our Global
PresenceProven Impact.
Precision in ExecutionAccelerated product readiness through compliance-aligned development, technical validation, and seamless transition from lab to launch.
From compliance to commercial success we’ve got you covered.
Questions
Yes ,we assess packaging feasibility for compliance and stability, and we review claims for regulatory alignment and substantiation.
No problem. The program is modular - you can engage for pilot batch execution or any other defined phase independently.
Absolutely. Through our partner lab network, we coordinate analytical, stability, and safety testing as part of the launch preparation process.
Yes, we conduct region-specific ingredient reviews to assess acceptability, regulatory status, and associated risks across target geographies.
This program is designed to support both early-stage concept development and post-formulation refinement. The earlier you engage, the more aligned your product will be with regulatory and market expectations.
Avoid costly pivots. Design for compliance. Build boldly. Regnova’s Innovation Commercialization Enablement program keeps your innovation moving at market speed.